Prognostic value of sepsis-induced coagulation abnormalities: an early assessment in the emergency department.
Aged
Aged, 80 and over
Antithrombin III
/ analysis
Biomarkers
/ analysis
Blood Coagulation Disorders
/ etiology
Emergency Service, Hospital
/ organization & administration
Female
Fibrin Fibrinogen Degradation Products
/ analysis
Humans
Male
Middle Aged
Organ Dysfunction Scores
Peptide Hydrolases
/ analysis
Predictive Value of Tests
Prognosis
Prospective Studies
Sepsis
/ complications
Coagulation abnormalities
Prognostic stratification
Sepsis
Journal
Internal and emergency medicine
ISSN: 1970-9366
Titre abrégé: Intern Emerg Med
Pays: Italy
ID NLM: 101263418
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
05
02
2018
accepted:
20
11
2018
pubmed:
12
12
2018
medline:
30
1
2020
entrez:
12
12
2018
Statut:
ppublish
Résumé
To evaluate if the assessment of coagulation abnormalities at ED admission could improve prognostic assessment of septic patients. This report utilizes a portion of the data collected in a prospective study, with the aim to identify reliable biomarkers for an early sepsis diagnosis. In the period November 2011-December 2016, we enrolled 268 patients, admitted to our High-Dependency Unit with a diagnosis severe sepsis/septic shock. Study-related blood samplings were performed at ED-HDU admission (T0), after 6 h (T6) and 24 h (T24): D-dimer, thrombin-antithrombin complex (TAT) and prothrombin fragment F1 + 2 levels were analyzed. The primary end-points were day-7 and in-hospital mortality. Day-7 mortality rate was 16%. D-dimer (T0: 4661 ± 4562 µg/ml vs 3190 ± 7188 µg/ml; T6: 4498 ± 4931 µg/ml vs 2822 ± 5623 µg/ml; T24 2905 ± 2823 µg/ml vs 2465 ± 4988 µg/ml, all p < 0.05) and TAT levels (T0 29 ± 45 vs 22 ± 83; T6 21 ± 22 vs 15 ± 35; T24 16 ± 19 vs 13 ± 30, all p < 0.05) were higher among non-survivors compared to survivors. We defined an abnormal coagulation activation (COAG+) as D-dimer > 500 µg/ml and TAT > 8 ng/ml (for both, twice the upper normal value). Compared to COAG-, COAG+ patients showed higher lactate levels at the earliest evaluations (T0: 3.3 ± 2.7 vs 2.5 ± 2.3, p = 0.041; T6: 2.8 ± 3.4 vs 1.8 ± 1.6, p = 0.015); SOFA score was higher after 24 h (T24: 6.7 ± 3.1 vs 5.4 ± 2.9, p = 0.008). At T0, COAG+ patients showed a higher day-7 mortality rate (HR 2.64; 95% CI 1.14-6.11, p = 0.023), after adjustment for SOFA score and lactate level. Presence of abnormal coagulation at ED admission shows an independent association with an increased short-term mortality rate.
Identifiants
pubmed: 30535649
doi: 10.1007/s11739-018-1990-z
pii: 10.1007/s11739-018-1990-z
doi:
Substances chimiques
Biomarkers
0
Fibrin Fibrinogen Degradation Products
0
antithrombin III-protease complex
0
fibrin fragment D
0
Antithrombin III
9000-94-6
Peptide Hydrolases
EC 3.4.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
459-466Références
Semin Thromb Hemost. 2015 Feb;41(1):9-15
pubmed: 25590524
Crit Care. 2004 Apr;8(2):R82-90
pubmed: 15025782
Crit Care Med. 2003 Apr;31(4):1250-6
pubmed: 12682500
Crit Care Med. 2009 May;37(5):1649-54
pubmed: 19325482
Am J Emerg Med. 2016 Sep;34(9):1788-93
pubmed: 27321936
Shock. 2005 Jun;23(6):488-93
pubmed: 15897799
Thromb Res. 2017 Jan;149:38-44
pubmed: 27886531
Crit Care Med. 2004 Dec;32(12):2416-21
pubmed: 15599145
Eur J Emerg Med. 2014 Aug;21(4):254-9
pubmed: 23970100
Crit Care. 2013 Apr 11;17(2):R68
pubmed: 23577792
Eur J Intern Med. 2015 Dec;26(10):782-6
pubmed: 26586287
Acta Anaesthesiol Scand. 2017 Aug;61(7):790-796
pubmed: 28681428
JAMA. 2001 Oct 10;286(14):1754-8
pubmed: 11594901
J Innate Immun. 2018;10(5-6):502-514
pubmed: 29763894
Br J Haematol. 2006 Oct;135(2):220-7
pubmed: 17010048
Crit Care Med. 2006 Feb;34(2):314-20; quiz 328
pubmed: 16424708
Blood Coagul Fibrinolysis. 2017 Mar;28(2):163-170
pubmed: 27254441
Crit Care. 2014 Jan 13;18(1):R13
pubmed: 24410881
Intern Emerg Med. 2018 Apr;13(3):405-412
pubmed: 28188577
Crit Care. 2010;14(5):R182
pubmed: 20942957